A newly tested combination therapy showed a higher rate of survival compared to chemotherapy alone, according to a study published July 24 in The New England Journal of Medicine.
Oncology
New York City-based NYU Langone Health's Perlmutter Cancer Center has named Jonathan Gerber, MD, its new chief clinical officer.
At-home fecal immunochemical test screening was found to reduce risk of colon cancer death by 33%, according to a study published July 19 in JAMA Network Open.
The number of cancer survivors in the U.S. has risen and is likely to continue to rise, according to a report from researchers at the National Cancer Institute in Rockville, Md., published July 13 in the Journal of the National…
The Ohio State University Wexner Medical Center in Columbus has partnered with population genomics company Helix to launch the largest precision health initiative in the state.
The U.S. News & World Report's "2024-25 Best Hospitals for Cancer" ranked the top cancer centers in every state.
There is a gender divide in oncologist net worth, according to the "Physician Wealth & Debt Report" published July 19 by Medscape.
The Fox Chase Cancer Center in Philadelphia has promoted Sanjay Reddy, MD, to surgical oncology division chief.
Researchers at the Yale School of Medicine in New Haven, Conn., found a Trojan horse therapy to be effective against a variety of cancerous tumors, including difficult-to-reach brain tumors, in a laboratory setting, according to a study published July 15…
The growing popularity of Ozempic and other GLP-1s in recent years is garnering greater attention from oncologists interested in how these drugs could affect cancer care and cancer rates.